186 related articles for article (PubMed ID: 32184726)
1. A Compartmentalized Reduction in Membrane-Proximal Calmodulin Reduces the Immune Surveillance Capabilities of CD8
Chimote AA; Gawali VS; Newton HS; Wise-Draper TM; Conforti L
Front Pharmacol; 2020; 11():143. PubMed ID: 32184726
[TBL] [Abstract][Full Text] [Related]
2. A defect in KCa3.1 channel activity limits the ability of CD8
Chimote AA; Balajthy A; Arnold MJ; Newton HS; Hajdu P; Qualtieri J; Wise-Draper T; Conforti L
Sci Signal; 2018 Apr; 11(527):. PubMed ID: 29692361
[TBL] [Abstract][Full Text] [Related]
3. PD1 blockade enhances K
Newton HS; Gawali VS; Chimote AA; Lehn MA; Palackdharry SM; Hinrichs BH; Jandarov R; Hildeman D; Janssen EM; Wise-Draper TM; Conforti L
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33060146
[TBL] [Abstract][Full Text] [Related]
4. Immune Checkpoint Inhibitors Regulate K
Gawali VS; Chimote AA; Newton HS; Feria-Garzón MG; Chirra M; Janssen EM; Wise-Draper TM; Conforti L
Front Pharmacol; 2021; 12():742862. PubMed ID: 34512366
[TBL] [Abstract][Full Text] [Related]
5. PKA reduces the rat and human KCa3.1 current, CaM binding, and Ca2+ signaling, which requires Ser332/334 in the CaM-binding C terminus.
Wong R; Schlichter LC
J Neurosci; 2014 Oct; 34(40):13371-83. PubMed ID: 25274816
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of KCa3.1 channels mediates adenosine regulation of the motility of human T cells.
Chimote AA; Hajdu P; Kucher V; Boiko N; Kuras Z; Szilagyi O; Yun YH; Conforti L
J Immunol; 2013 Dec; 191(12):6273-80. PubMed ID: 24227782
[TBL] [Abstract][Full Text] [Related]
7. Structural Determinants for the Selectivity of the Positive KCa3.1 Gating Modulator 5-Methylnaphtho[2,1-
Brown BM; Shim H; Zhang M; Yarov-Yarovoy V; Wulff H
Mol Pharmacol; 2017 Oct; 92(4):469-480. PubMed ID: 28760780
[TBL] [Abstract][Full Text] [Related]
8. Targeted knockdown of the adenosine A
Newton HS; Chimote AA; Arnold MJ; Wise-Draper TM; Conforti L
Mol Ther Methods Clin Dev; 2021 Jun; 21():133-143. PubMed ID: 33816646
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Interleukin 10 Transcription through the SMAD2/3 Signaling Pathway by Ca
Matsui M; Kajikuri J; Kito H; Endo K; Hasegawa Y; Murate S; Ohya S
Mol Pharmacol; 2019 Mar; 95(3):294-302. PubMed ID: 30622214
[TBL] [Abstract][Full Text] [Related]
10. KCa3.1/IK1 Channel Regulation by cGMP-Dependent Protein Kinase (PKG) via Reactive Oxygen Species and CaMKII in Microglia: An Immune Modulating Feedback System?
Ferreira R; Wong R; Schlichter LC
Front Immunol; 2015; 6():153. PubMed ID: 25904916
[TBL] [Abstract][Full Text] [Related]
11. Blockade of adenosine A2A receptor enhances CD8
Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
[TBL] [Abstract][Full Text] [Related]
12. Differentially Expressed Potassium Channels Are Associated with Function of Human Effector Memory CD8
Sim JH; Kim KS; Park H; Kim KJ; Lin H; Kim TJ; Shin HM; Kim G; Lee DS; Park CW; Lee DH; Kang I; Kim SJ; Cho CH; Doh J; Kim HR
Front Immunol; 2017; 8():859. PubMed ID: 28791017
[TBL] [Abstract][Full Text] [Related]
13. Cancer-Associated Intermediate Conductance Ca
Mohr CJ; Steudel FA; Gross D; Ruth P; Lo WY; Hoppe R; Schroth W; Brauch H; Huber SM; Lukowski R
Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30658505
[TBL] [Abstract][Full Text] [Related]
14. Intracellular acidity impedes KCa3.1 activation by Riluzole and SKA-31.
Cozzolino M; Panyi G
Front Pharmacol; 2024; 15():1380655. PubMed ID: 38638868
[TBL] [Abstract][Full Text] [Related]
15. The effect of Curcumin on multi-level immune checkpoint blockade and T cell dysfunction in head and neck cancer.
Liu L; Lim MA; Jung SN; Oh C; Won HR; Jin YL; Piao Y; Kim HJ; Chang JW; Koo BS
Phytomedicine; 2021 Nov; 92():153758. PubMed ID: 34592487
[TBL] [Abstract][Full Text] [Related]
16. Activity of Potassium Channels in CD8
Jusztus V; Medyouni G; Bagosi A; Lampé R; Panyi G; Matolay O; Maka E; Krasznai ZT; Vörös O; Hajdu P
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396628
[TBL] [Abstract][Full Text] [Related]
17. Laminar shear stress upregulates endothelial Ca²⁺-activated K⁺ channels KCa2.3 and KCa3.1 via a Ca²⁺/calmodulin-dependent protein kinase kinase/Akt/p300 cascade.
Takai J; Santu A; Zheng H; Koh SD; Ohta M; Filimban LM; Lemaître V; Teraoka R; Jo H; Miura H
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H484-93. PubMed ID: 23792675
[TBL] [Abstract][Full Text] [Related]
18. Toward the rational design of constitutively active KCa3.1 mutant channels.
Garneau L; Klein H; Parent L; Sauvé R
Methods Enzymol; 2010; 485():437-57. PubMed ID: 21050931
[TBL] [Abstract][Full Text] [Related]
19. Orai/CRACM1 and KCa3.1 ion channels interact in the human lung mast cell plasma membrane.
Duffy SM; Ashmole I; Smallwood DT; Leyland ML; Bradding P
Cell Commun Signal; 2015 Jul; 13():32. PubMed ID: 26177720
[TBL] [Abstract][Full Text] [Related]
20. Development of a QPatch automated electrophysiology assay for identifying KCa3.1 inhibitors and activators.
Jenkins DP; Yu W; Brown BM; Løjkner LD; Wulff H
Assay Drug Dev Technol; 2013; 11(9-10):551-60. PubMed ID: 24351043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
